{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:51:42Z","timestamp":1791046302880,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Background. Cutaneous adverse drug reactions (CADRs) are common skin adverse reactions associated with drugs.<\/jats:p>\n               <jats:p>Aim. To assess recent trends in CADRs and the drugs associated with them, using data from the past 5 years in the largest single database available on a hospital-based population in China.<\/jats:p>\n               <jats:p>Methods. All clinical records of inpatients admitted with a diagnosis of CADR to the Dermatology Ward, Huashan Hospital from January 2004 to December 2008 were retrospectively studied.<\/jats:p>\n               <jats:p>Results. In the 734 patients, the three most common types of CADRs were nonsevere reactions, erythema multiforme (EM)-like eruptions (n = 255), urticaria (n = 192) and exanthematous reactions (n = 159), followed by three severe reactions: Stevens\u2013Johnson syndrome (n = 58), toxic epidermal necrolysis (n = 29) and exfoliative dermatitis (n = 22). The most common single drug associated with the development of all drug eruptions was allopurinol, followed by amoxicillin, cephalosporins, antiepileptic agents and antipyretic\/analgesic agents. However, the most common single drugs associated with severe reactions were antiepileptic agents, followed by allopurinol, antipyretic\/analgesic agents and cephalosporins. In contrast to patients with nonsevere reactions, patients with severe reactions were more likely to be male (P &amp;lt; 0.001) and to have a greater mean age of onset (P &amp;lt; 0.001), a longer latency period (P &amp;lt; 0.001) and a longer duration of hospitalization (P &amp;lt; 0.001).<\/jats:p>\n               <jats:p>Conclusion. In contrast to previous studies, we found allopurinol to be the most common single drug associated with CADRs followed by antibiotics (amoxicillin and cephalosporins), and antiepileptic, especially carbamazepine. A higher incidence of EM-like eruptions and urticaria was also seen.<\/jats:p>","DOI":"10.1111\/j.1365-2230.2010.03922.x","type":"journal-article","created":{"date-parts":[[2010,8,29]],"date-time":"2010-08-29T20:24:40Z","timestamp":1283113480000},"page":"135-141","source":"Crossref","is-referenced-by-count":27,"title":["Cutaneous adverse drug reactions in a hospital-based Chinese population"],"prefix":"10.1093","volume":"36","author":[{"given":"H.-Y.","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-Q.","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-S.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Illinois College of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.-H.","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-F.","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"2023012703535982900_b1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"2023012703535982900_b2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"2023012703535982900_b3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","article-title":"Acute generalized exanthematous pustulosis Analysis of 63 cases","volume":"127","author":"Roujeau","year":"1991","journal-title":"Arch Dermatol"},{"key":"2023012703535982900_b4","first-page":"223","article-title":"Cutaneous drug reactions: clinical types and causative agents A five-year survey of in patients (1981\u20131985)","volume":"69","author":"Alanko","year":"1989","journal-title":"Acta Dermatol Venereol"},{"key":"2023012703535982900_b5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-4362.1993.tb02829.x","article-title":"Identifying skin reactions to drugs","volume":"32","author":"Sacerdoti","year":"1993","journal-title":"Int J Dermatol"},{"key":"2023012703535982900_b6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0738-081X(93)90150-B","article-title":"Epidemiology of bullous drug eruptions","volume":"11","author":"Breathnach","year":"1993","journal-title":"Clin Dermatol"},{"key":"2023012703535982900_b7","first-page":"1633","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Stern","year":"1999"},{"key":"2023012703535982900_b8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-4362.1998.00378.x","article-title":"Drug eruptions in Bangkok: a 1-year study at Ramathibodi Hospital","volume":"37","author":"Puavilai","year":"1998","journal-title":"Int J Dermatol"},{"key":"2023012703535982900_b9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2125.1999.00096.x","article-title":"Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions","volume":"48","author":"Naldi","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2023012703535982900_b10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2332\/allergolint.O-07-483","article-title":"Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006","volume":"56","author":"Yamane","year":"2007","journal-title":"Allergol Int"},{"key":"2023012703535982900_b11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2023012703535982900_b12","volume-title":"Modern Dermatology","author":"Yang","year":"1995"},{"key":"2023012703535982900_b13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2230.2006.02185.x","article-title":"Epidemiological study of severe cutaneous adverse drug reactions in a city district of China","volume":"31","author":"Li","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"2023012703535982900_b14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4103\/0378-6323.42883","article-title":"Clinical study of cutaneous drug eruptions in 200 patients","volume":"74","author":"Patel","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2023012703535982900_b15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/pds.1105","article-title":"Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital","volume":"14","author":"Sushma","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2023012703535982900_b16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2008.09.015","article-title":"Cutaneous drug eruptions: a 5-year experience","volume":"59","author":"Gerson","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2023012703535982900_b17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-4362.1998.00490.x","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia","volume":"37","author":"Kamaliah","year":"1998","journal-title":"Int J Dermatol"},{"key":"2023012703535982900_b18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1445-5994.2005.00790.x","article-title":"Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case\u2013control study","volume":"35","author":"Lin","year":"2005","journal-title":"Intern Med J"},{"key":"2023012703535982900_b19","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1136\/bmj.290.6486.1969","article-title":"Asymptomatic hyperuricemia and allopurinol induced toxic epidermal necrolysis","volume":"290","author":"Aubock","year":"1985","journal-title":"Br Med J"},{"key":"2023012703535982900_b20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2023012703535982900_b21","volume-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2006"},{"key":"2023012703535982900_b22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0378-6323.16782","article-title":"Carbamazepine \u2013 the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years","volume":"71","author":"Devi","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2023012703535982900_b23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"8","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"2023012703535982900_b24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"2023012703535982900_b25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1309\/P024K7VRDDPJCTVN","article-title":"Review of abnormal laboratory test results and toxic effects due to use of herbal medicines","volume":"120","author":"Dasgupta","year":"2003","journal-title":"Am J Clin Pathol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2010.03922.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/36\/2\/135\/46911824\/ced0135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/36\/2\/135\/46911824\/ced0135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T04:08:33Z","timestamp":1674792513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/36\/2\/135\/6622233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,3,1]]},"published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03922.x","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,3,1]]},"published":{"date-parts":[[2011,3,1]]}}}